Literature DB >> 18989932

Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.

Ravi Prakash Reddy Nanga1, Jeffrey R Brender, Jiadi Xu, Gianluigi Veglia, Ayyalusamy Ramamoorthy.   

Abstract

Disruption of the cellular membrane by the amyloidogenic peptide IAPP (or amylin) has been implicated in beta-cell death during type 2 diabetes. While the structure of the mostly inert fibrillar form of IAPP has been investigated, the structural details of the highly toxic prefibrillar membrane-bound states of IAPP have been elusive. A recent study showed that a fragment of IAPP (residues 1-19) induces membrane disruption to a similar extent as the full-length peptide. However, unlike the full-length IAPP peptide, IAPP(1-19) is conformationally stable in an alpha-helical conformation when bound to the membrane. In vivo and in vitro measurements of membrane disruption indicate the rat version of IAPP(1-19), despite differing from hIAPP(1-19) by the single substitution of Arg18 for His18, is significantly less toxic than hIAPP(1-19), in agreement with the low toxicity of the full-length rat IAPP peptide. To investigate the origin of this difference at the atomic level, we have solved the structures of the human and rat IAPP(1-19) peptides in DPC micelles. While both rat and human IAPP(1-19) fold into similar mostly alpha-helical structures in micelles, paramagnetic quenching NMR experiments indicate a significant difference in the membrane orientation of hIAPP(1-19) and rIAPP(1-19). At pH 7.3, the more toxic hIAPP(1-19) peptide is buried deeper within the micelle, while the less toxic rIAPP(1-19) peptide is located at the surface of the micelle. Deprotonating H18 in hIAPP(1-19) reorients the peptide to the surface of the micelle. This change in orientation is in agreement with the significantly reduced ability of hIAPP(1-19) to cause membrane disruption at pH 6.0. This difference in peptide topology in the membrane may correspond to similar topology differences for the full-length human and rat IAPP peptides, with the toxic human IAPP peptide adopting a transmembrane orientation and the nontoxic rat IAPP peptide bound to the surface of the membrane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989932      PMCID: PMC2953382          DOI: 10.1021/bi8014357

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

2.  Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide.

Authors:  Yariv Mazor; Sharon Gilead; Itai Benhar; Ehud Gazit
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

3.  NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles.

Authors:  Jamillah Zamoon; Alessandro Mascioni; David D Thomas; Gianluigi Veglia
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

4.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.

Authors:  E T Jaikaran; C E Higham; L C Serpell; J Zurdo; M Gross; A Clark; P E Fraser
Journal:  J Mol Biol       Date:  2001-05-04       Impact factor: 5.469

5.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

6.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.

Authors:  Orlando Crescenzi; Simona Tomaselli; Remo Guerrini; Severo Salvadori; Anna M D'Ursi; Piero Andrea Temussi; Delia Picone
Journal:  Eur J Biochem       Date:  2002-11

7.  Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study.

Authors:  Alessandro Mascioni; Fernando Porcelli; Udayar Ilangovan; Ayyalusamy Ramamoorthy; Gianluigi Veglia
Journal:  Biopolymers       Date:  2003-05       Impact factor: 2.505

Review 8.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

9.  Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.

Authors:  Katherine A Henzler-Wildman; Gary V Martinez; Michael F Brown; A Ramamoorthy
Journal:  Biochemistry       Date:  2004-07-06       Impact factor: 3.162

10.  Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.

Authors:  Marcus Bokvist; Fredrick Lindström; Anthony Watts; Gerhard Gröbner
Journal:  J Mol Biol       Date:  2004-01-23       Impact factor: 5.469

View more
  69 in total

1.  Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide.

Authors:  Mazin Magzoub; Andrew D Miranker
Journal:  FASEB J       Date:  2011-12-19       Impact factor: 5.191

2.  Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.

Authors:  Jeffrey R Brender; Samer Salamekh; Ayyalusamy Ramamoorthy
Journal:  Acc Chem Res       Date:  2011-09-25       Impact factor: 22.384

3.  Single-molecule fluorescence spectroscopy using phospholipid bilayer nanodiscs.

Authors:  Abhinav Nath; Adam J Trexler; Peter Koo; Andrew D Miranker; William M Atkins; Elizabeth Rhoades
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

4.  Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

Authors:  Jeffrey R Brender; Edgar L Lee; Kevin Hartman; Pamela T Wong; Ayyalusamy Ramamoorthy; Duncan G Steel; Ari Gafni
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

Review 5.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

Review 6.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

7.  Islet amyloid polypeptide toxicity and membrane interactions.

Authors:  Ping Cao; Andisheh Abedini; Hui Wang; Ling-Hsien Tu; Xiaoxue Zhang; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

8.  Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments.

Authors:  Jeffrey R Brender; Deborah L Heyl; Shyamprasad Samisetti; Samuel A Kotler; Joshua M Osborne; Ranadheer R Pesaru; Ayyalusamy Ramamoorthy
Journal:  Phys Chem Chem Phys       Date:  2013-03-15       Impact factor: 3.676

Review 9.  Considering protonation as a posttranslational modification regulating protein structure and function.

Authors:  André Schönichen; Bradley A Webb; Matthew P Jacobson; Diane L Barber
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

10.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.

Authors:  Jeffrey R Brender; Kevin Hartman; Kendra R Reid; Robert T Kennedy; Ayyalusamy Ramamoorthy
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.